Smart Contact Lenses & Tear Glucose

Introduction to Smart Contact Lenses & Tear [Glucose Monitoring](/)

Background

A glucose-sensing contact lens would read sugar levels in the thin film of tears on the eye, with no fingerstick and no sensor under the skin. As of October 2026, it is still a research idea. When we searched FDA's 510(k) and premarket approval (PMA) databases, we found no contact lens cleared or approved to measure glucose [6][7]. The appeal is easy to understand: Google's 2014 announcement of its lens project pointed out that fingersticks are disruptive and painful, and that many people with diabetes check less often as a result [1].

Innovation and Patents

The best-known attempt came from Google. In January 2014, its Google[x] lab said it was testing a soft lens with a tiny wireless chip and a miniaturized glucose sensor sealed between two layers of lens material, and that the prototypes could take a reading once per second [1]. The same post said Google was in discussions with the FDA and wanted a partner experienced in bringing such products to market [1]. That partner was Alcon, then the eye-care unit of Novartis, working with Verily, Google's life-sciences company [3].

The project did not survive. A 2021 review of CGM history reports that it was abandoned in November 2018 because measuring glucose in tears proved unreliable [3]. Here's what surprised us: a separate 2022 review argues the stated reason was narrower than "tears don't track blood." It points to the very small amount of glucose in tears and to contaminants that interfere with the measurement [4].

Manufacturers and Product Lines

As of October 2026, no smart contact lens for glucose monitoring is sold in the United States, and none appears in FDA's clearance or approval records [6][7]. A 2022 survey of noninvasive and minimally invasive glucose products listed the Novartis and Verily lens among devices that were announced as in development and then disappeared from public view [5].

Some companies come up often in smart-lens coverage without working on glucose. Mojo Vision, for example, introduced an augmented-reality lens concept in early 2020 that displayed items such as a calendar, music controls and weather, not glucose readings [4].

Effectiveness and Technology

Tear glucose does rise and fall with blood glucose, but it trails behind, and the amount is small. A 2022 review summarized studies showing that tear glucose correlates with blood glucose yet lags it by 10 to 20 minutes [2]. In one animal study the review describes, a sensor lens on a rabbit's eye recorded a tear-glucose rise 15 to 20 minutes behind blood glucose after an oral glucose dose [2]. Even Google's 2014 post acknowledged that tears are hard to collect and study [1].

Researchers have built three broad kinds of sensors into lenses. Fluorescent sensors change how much light they emit when glucose binds to them. Light-diffractive sensors, built from photonic crystals, shift the wavelength, or color, of the light they diffract. Electrochemical sensors use an enzyme to turn glucose into a small electrical current, which means they need power and usually carry opaque metal parts and chips that can block vision and reduce oxygen reaching the eye [2]. Every design still has to fit inside a thin, clear lens that sits on the eye for hours.

Pitfalls, Warnings, and Issues

The open problems are the same ones that stopped the Verily and Alcon program, plus the practical limits of anything worn on the eye:

• Accuracy. Tear glucose lags blood glucose and is present in small amounts, so a lens reading may not match a blood reading taken at the same moment [2][4].
• Comfort and eye health. Contact lens wear can itself cause side effects such as dry eye, which makes an all-day sensor lens harder to design [4].
• Electronics on the eye. Researchers still list opaque electronic materials, device-to-device reliability and biocompatibility as problems to solve before these lenses can be sold [4].
• Regulation. The 2022 survey named the lack of a clear regulatory pathway among the barriers facing noninvasive glucose monitors [5]. We cover that process in Regulatory Pathways for Non-Invasive Devices.
• Data security and privacy, as with any wireless device that sends health data to a phone.

Conclusion

Tear glucose sensing has had one large, well-funded test, and it ended in 2018 because the readings weren't reliable enough [3]. What nobody has shown yet is a lens that overcomes the small glucose signal in tears and its lag behind blood [2][4]. Until one appears in FDA's records, a glucose contact lens remains a research topic rather than a device you can get [6][7].